Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-07-21

Clinical Trial Update: Pharmacokinetic Study of ADVATE Reconstituted in 2 mL Sterile Water for Injection [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study of ADVATE reconstituted in 2 mL sterile water for injection; study completed with results posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ADVATE (antihemophilic factor VIII)

Snippet

Sponsor: Baxalta now part of Shire | Conditions: Hemophilia A | Phase 1 | Status: COMPLETED | Results posted: 2011-07-21